BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11516452)

  • 21. Venous thromboembolic disease and cancer.
    Fennerty A
    Postgrad Med J; 2006 Oct; 82(972):642-8. PubMed ID: 17068274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical practice-based evaluation of the RIETE score in predicting occult cancer in patients with venous thromboembolism.
    Rosell A; Lundström S; Mackman N; Wallén H; Thålin C
    J Thromb Thrombolysis; 2019 Jul; 48(1):111-118. PubMed ID: 30739306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism.
    Di Minno G; Mannucci PM; Tufano A; Palareti G; Moia M; Baccaglini U; Rudelli G; Giudici GA;
    J Thromb Haemost; 2005 Jul; 3(7):1459-66. PubMed ID: 15978103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
    Robin P; Carrier M
    Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult cancer in older patients presenting with venous thromboembolism.
    Kelly J; Rudd T; Lewis R; Hunt B
    Age Ageing; 2002 Mar; 31(2):101-4. PubMed ID: 11937473
    [No Abstract]   [Full Text] [Related]  

  • 27. Real-world experience with limited screening for occult malignancy in patients presenting with spontaneous venous thromboembolism: a single-centre, retrospective cohort study.
    Grainger BT; McCrea TA; Eaddy N; Ockelford P; Young L
    Intern Med J; 2022 Mar; 52(3):491-494. PubMed ID: 35307933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future.
    van Es N; Ay C; Jara-Palomares L
    Hamostaseologie; 2020 Aug; 40(3):270-279. PubMed ID: 32726822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Has time come for screening for occult cancer in patients with venous thromboembolism?
    Büller HR
    J Thromb Haemost; 2004 Jun; 2(6):874-5. PubMed ID: 15140119
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypercoagulable state testing and malignancy screening following venous thromboembolic events.
    Deitcher SR; Gomes MP
    Vasc Med; 2003; 8(1):33-46. PubMed ID: 12866610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
    Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
    Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Venous thromboembolism and cancer].
    Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
    Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do we need a cancer screening in patients with idiopathic deep vein thrombosis?
    Gaitini DE; Brenner B
    Ultraschall Med; 2008 Dec; 29 Suppl 5():220-5. PubMed ID: 19177286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening for cancer in case of venous thromboembolism: when and how?].
    Sevestre MA
    Rev Prat; 2022 Mar; 72(3):267-269. PubMed ID: 35638947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and management of venous thromboembolism in patients with cancer.
    Lee AY
    Thromb Res; 2003 Jun; 110(4):167-72. PubMed ID: 14512077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.
    Patel SS; Tao D; McMurry HS; Shatzel JJ
    Eur J Haematol; 2023 Jan; 110(1):24-31. PubMed ID: 36192850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see?
    Prins MH; Hettiarachchi RJ; Lensing AW; Hirsh J
    Thromb Haemost; 1997 Jul; 78(1):121-5. PubMed ID: 9198140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of occult cancer in patients with idiopathic venous thrombosis].
    Holt MI; Knudsen ST; Andersen BS; Grove EL
    Ugeskr Laeger; 2015 Jul; 177(29):. PubMed ID: 26239961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.